Goodrx Holdings
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $200,610 | $197,880 | $196,644 | $179,958 |
Gross Profit | 171,775 | 169,470 | 139,138 | 161,237 |
EBITDA | 37,583 | 36,372 | 29,239 | 1,143 |
EBIT | 20,618 | 20,430 | -15,451 | -14,381 |
Net Income | 6,694 | -1,008 | -25,869 | -38,495 |
Net Change In Cash | 200,610 | 197,880 | 196,644 | 179,958 |
Free Cash Flow | -7,528 | 21,971 | 2,996 | 46,623 |
Cash | 524,903 | 533,294 | 672,296 | 794,905 |
Basic Shares | 384,732 | 390,048 | 403,248 | 413,437 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $750,265 | $766,554 | $745,424 | $550,700 |
Gross Profit | 580,172 | 701,475 | 698,708 | 521,113 |
EBITDA | 163,148 | 65,189 | 48,004 | -257,107 |
EBIT | 51,376 | 7,663 | 10,363 | -280,015 |
Net Income | -8,868 | -32,828 | -25,254 | -293,623 |
Net Change In Cash | 750,265 | 766,554 | 745,424 | 550,700 |
Cost of Revenue | -183,944 | -30,482 | 945,541 | |
Free Cash Flow | 82,526 | 91,566 | 144,322 | 95,517 |
Cash | 672,296 | 757,165 | 941,109 | 968,691 |
Basic Shares | 410,315 | 412,858 | 400,562 | 391,660 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | $0.08 |
2024-03-31 | $0.08 |
2023-12-31 | $0.08 |
2023-09-30 | $0.06 |
